Laboratory Corporation of America Holdings (LH) Shares Bought by Tredje AP fonden

Tredje AP fonden boosted its stake in shares of Laboratory Corporation of America Holdings (NYSE:LH) by 43.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 18,539 shares of the company’s stock after buying an additional 5,619 shares during the period. Tredje AP fonden’s holdings in Laboratory Corporation of America Holdings were worth $2,380,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. BlackRock Investment Management LLC boosted its position in shares of Laboratory Corporation of America Holdings by 0.3% in the second quarter. BlackRock Investment Management LLC now owns 714,432 shares of the company’s stock worth $93,069,000 after buying an additional 1,913 shares during the last quarter. Neuberger Berman Group LLC boosted its position in shares of Laboratory Corporation of America Holdings by 97.1% in the second quarter. Neuberger Berman Group LLC now owns 8,629 shares of the company’s stock worth $1,124,000 after buying an additional 4,251 shares during the last quarter. Bank of The West boosted its position in shares of Laboratory Corporation of America Holdings by 3.0% in the second quarter. Bank of The West now owns 17,442 shares of the company’s stock worth $2,272,000 after buying an additional 500 shares during the last quarter. BRC Investment Management LLC bought a new position in shares of Laboratory Corporation of America Holdings during the second quarter worth about $6,671,000. Finally, Concourse Capital Management LLC bought a new position in shares of Laboratory Corporation of America Holdings during the second quarter worth about $1,914,000. Institutional investors own 91.59% of the company’s stock.

Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)

Shares of Laboratory Corporation of America Holdings (NYSE:LH) traded down 0.10% on Friday, hitting $138.99. The stock had a trading volume of 145,734 shares. The firm has a 50 day moving average price of $133.14 and a 200 day moving average price of $132.90. Laboratory Corporation of America Holdings has a one year low of $106.01 and a one year high of $141.32. The company has a market capitalization of $14.32 billion, a P/E ratio of 22.04 and a beta of 0.94.

Laboratory Corporation of America Holdings (NYSE:LH) last posted its quarterly earnings data on Thursday, February 16th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.02. Laboratory Corporation of America Holdings had a return on equity of 16.97% and a net margin of 6.85%. The firm had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the business earned $1.98 EPS. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities research analysts predict that Laboratory Corporation of America Holdings will post $8.80 earnings per share for the current fiscal year.

“Laboratory Corporation of America Holdings (LH) Shares Bought by Tredje AP fonden” was reported by Web Breaking News and is the property of of Web Breaking News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this news story can be read at http://www.webbreakingnews.com/2017/02/17/laboratory-corporation-of-america-holdings-lh-shares-bought-by-tredje-ap-fonden.html.

LH has been the topic of a number of recent research reports. Gabelli initiated coverage on Laboratory Corporation of America Holdings in a report on Tuesday, October 25th. They issued a “buy” rating and a $180.00 target price on the stock. Zacks Investment Research cut Laboratory Corporation of America Holdings from a “hold” rating to a “sell” rating in a report on Wednesday, December 28th. Canaccord Genuity set a $140.00 target price on Laboratory Corporation of America Holdings and gave the stock a “buy” rating in a report on Sunday, October 30th. Mizuho lifted their target price on Laboratory Corporation of America Holdings from $135.00 to $139.00 and gave the stock a “neutral” rating in a report on Friday. Finally, Deutsche Bank AG restated a “buy” rating and issued a $170.00 target price on shares of Laboratory Corporation of America Holdings in a report on Wednesday, January 18th. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $147.07.

Laboratory Corporation of America Holdings Company Profile

Laboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

5 Day Chart for NYSE:LH

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

Receive News & Ratings for Laboratory Corporation of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corporation of America Holdings and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.